Compare AX & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AX | ICUI |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 3.9B |
| IPO Year | 2004 | 1995 |
| Metric | AX | ICUI |
|---|---|---|
| Price | $84.01 | $126.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $103.14 | ★ $182.25 |
| AVG Volume (30 Days) | ★ 301.2K | 266.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | ★ 4.17 | 0.03 |
| Revenue | $65,789,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $25.09 | N/A |
| Revenue Next Year | $10.96 | $4.46 |
| P/E Ratio | ★ $20.30 | $4,287.33 |
| Revenue Growth | ★ 1.78 | N/A |
| 52 Week Low | $54.46 | $107.02 |
| 52 Week High | $101.92 | $160.29 |
| Indicator | AX | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 34.15 | 29.24 |
| Support Level | $83.86 | $121.49 |
| Resistance Level | $89.12 | $136.39 |
| Average True Range (ATR) | 3.41 | 5.54 |
| MACD | -0.82 | -2.01 |
| Stochastic Oscillator | 15.92 | 8.59 |
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.